Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEF POTEE POTEI	2.60e-05	11	110	3	GO:0098973
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	ANK3 POTEF SPTAN1 SPTBN4 POTEE POTEI	8.35e-05	130	110	6	GO:0005200
GeneOntologyMolecularFunction	damaged DNA binding	CUL4B RAD18 WRN ZNF782 EP300	1.01e-04	84	110	5	GO:0003684
GeneOntologyMolecularFunction	Y-form DNA binding	RAD18 WRN	1.79e-04	4	110	2	GO:0000403
GeneOntologyCellularComponent	paranode region of axon	ANK3 SPTAN1 SPTBN4	9.64e-05	17	112	3	GO:0033270
GeneOntologyCellularComponent	intracellular protein-containing complex	CUL4B RAD18 PCGF1 CNOT10 POTEF MED8 PSMD7 ZNFX1 TRAPPC8 POTEE GLMN DGCR8 WDR41 POTEI EP300	2.13e-04	972	112	15	GO:0140535
Domain	Ankyrin_rpt	POTEB3 TRPM4 ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	5.36e-09	262	111	13	IPR002110
Domain	ANK	POTEB3 ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	3.25e-08	251	111	12	SM00248
Domain	ANK_REPEAT	POTEB3 ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	3.54e-08	253	111	12	PS50088
Domain	ANK_REP_REGION	POTEB3 ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	3.70e-08	254	111	12	PS50297
Domain	Ank_2	POTEB3 ASZ1 ANK3 POTEF POTEG POTEC POTEE POTEM MIB1 PPP1R16B POTEI	6.30e-08	215	111	11	PF12796
Domain	Ank	ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	1.14e-07	228	111	11	PF00023
Domain	-	POTEB3 ASZ1 ANK3 POTEF POTEG POTEC POTEE POTEM MIB1 PPP1R16B POTEI	2.67e-07	248	111	11	1.25.40.20
Domain	Ankyrin_rpt-contain_dom	POTEB3 ASZ1 ANK3 POTEF POTEG POTEC POTEE POTEM MIB1 PPP1R16B POTEI	3.38e-07	254	111	11	IPR020683
Domain	SLRP_I_decor/aspor/byglycan	DCN BGN	1.05e-04	3	111	2	IPR016352
Domain	Actin_CS	POTEF POTEE POTEI	1.08e-04	16	111	3	IPR004001
Domain	ACTINS_2	POTEF POTEE POTEI	1.31e-04	17	111	3	PS00432
Domain	Actin/actin-like_CS	POTEF POTEE POTEI	1.56e-04	18	111	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEF POTEE POTEI	1.85e-04	19	111	3	PS01132
Domain	Actin	POTEF POTEE POTEI	8.13e-04	31	111	3	IPR004000
Domain	Actin	POTEF POTEE POTEI	8.13e-04	31	111	3	PF00022
Domain	ACTIN	POTEF POTEE POTEI	8.13e-04	31	111	3	SM00268
Domain	DHC_N1	DNAH8 DNAH9	9.57e-04	8	111	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH8 DNAH9	9.57e-04	8	111	2	IPR013594
Domain	AAA	ABCA2 RNF213 DMC1 DNAH8 DNAH9	1.69e-03	144	111	5	SM00382
Domain	AAA+_ATPase	ABCA2 RNF213 DMC1 DNAH8 DNAH9	1.69e-03	144	111	5	IPR003593
Domain	zf-C3HC4	RAD18 PCGF1 TRIM2 VPS8 RNF213 MIB1	2.17e-03	223	111	6	PF00097
Domain	Chemokine_CXC_CS	CXCL2 CXCL3	2.62e-03	13	111	2	IPR018048
Domain	DEATH-like_dom	ANK3 IFI16 NLRC4 NLRP8	2.88e-03	99	111	4	IPR011029
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH9	3.04e-03	14	111	2	IPR024317
Domain	Dynein_HC_stalk	DNAH8 DNAH9	3.04e-03	14	111	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH8 DNAH9	3.04e-03	14	111	2	IPR013602
Domain	CXC_Chemokine_domain	CXCL2 CXCL3	3.04e-03	14	111	2	IPR033899
Domain	DHC_N2	DNAH8 DNAH9	3.04e-03	14	111	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH9	3.04e-03	14	111	2	IPR011704
Domain	MT	DNAH8 DNAH9	3.04e-03	14	111	2	PF12777
Domain	AAA_8	DNAH8 DNAH9	3.04e-03	14	111	2	PF12780
Domain	AAA_5	DNAH8 DNAH9	3.04e-03	14	111	2	PF07728
Domain	DHC_fam	DNAH8 DNAH9	3.49e-03	15	111	2	IPR026983
Domain	Dynein_heavy	DNAH8 DNAH9	3.49e-03	15	111	2	PF03028
Domain	Dynein_heavy_dom	DNAH8 DNAH9	3.49e-03	15	111	2	IPR004273
Domain	EMI_domain	EMILIN3 POSTN	3.98e-03	16	111	2	IPR011489
Domain	Chemokine_CXC	CXCL2 CXCL3	3.98e-03	16	111	2	IPR001089
Domain	ARM-type_fold	RSPH14 UBR4 ARMC10 ZNFX1 THADA NF1 INTS4	4.14e-03	339	111	7	IPR016024
Domain	EMI	EMILIN3 POSTN	4.49e-03	17	111	2	PS51041
Domain	SMALL_CYTOKINES_CXC	CXCL2 CXCL3	4.49e-03	17	111	2	PS00471
Domain	ZF_ZZ_2	MIB1 EP300	5.03e-03	18	111	2	PS50135
Domain	ZF_ZZ_1	MIB1 EP300	5.03e-03	18	111	2	PS01357
Domain	ZZ	MIB1 EP300	5.03e-03	18	111	2	PF00569
Domain	-	RAD18 PCGF1 TRIM2 VPS8 RNF213 USP16 MIB1 FGD6	5.36e-03	449	111	8	3.30.40.10
Domain	Znf_ZZ	MIB1 EP300	5.60e-03	19	111	2	IPR000433
Domain	ZnF_ZZ	MIB1 EP300	5.60e-03	19	111	2	SM00291
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEF POTEG POTEE POTEM POTEI	8.85e-10	15	111	5	16824795
Pubmed	Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.	POTEB3 POTEG POTED POTEE	3.41e-09	7	111	4	15276201
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTED POTEE POTEM POTEI	1.22e-08	9	111	4	16364570
Pubmed	The Vertebrate Genome Annotation browser 10 years on.	POTEB3 POTEF POTEG ZNFX1 POTEC POTEE POTEM POTEI	5.74e-08	163	111	8	24316575
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	ABCA2 ZNFX1 PLXND1 TAOK2 SPTBN4 SETDB1 KATNIP	2.13e-07	130	111	7	12421765
Pubmed	Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.	POTEG POTEC POTEM	6.28e-07	6	111	3	17171436
Pubmed	In vivo assembly of the axon initial segment in motor neurons.	ANK3 SPTAN1 SPTBN4	6.28e-07	6	111	3	23728480
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NRIP1 ABCA2 ANK3 RSL1D1 PPFIBP1 SPTAN1 UBR4 PSMD7 ZNFX1 DCN USP16 SPTBN4 SETDB1 MIB1 PPP1R16B DGCR8 EP300	6.90e-07	1285	111	17	35914814
Pubmed	POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.	POTEB3 POTED POTEC	1.75e-06	8	111	3	12475935
Pubmed	Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression.	CXCL2 CXCL3 EP300	5.12e-06	11	111	3	15616592
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SMAP1 ANK3 RSL1D1 PPFIBP1 WRN RNF213 PSMD7 PLXND1 LSM12 THADA DGCR8 WDR41	7.44e-06	777	111	12	35844135
Pubmed	Neonatal Achilles Tendon Microstructure is Negatively Impacted by Decorin and Biglycan Knockdown After Injury and During Development.	DCN BGN	1.01e-05	2	111	2	38079083
Pubmed	Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice.	DCN BGN	1.01e-05	2	111	2	17188951
Pubmed	Expression and localization of the small proteoglycans decorin and biglycan in articular cartilage of Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency.	DCN BGN	1.01e-05	2	111	2	31478096
Pubmed	Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.	EP300 MYB	1.01e-05	2	111	2	34256093
Pubmed	Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74.	CXCL2 CXCL3	1.01e-05	2	111	2	9873037
Pubmed	C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	25783894
Pubmed	The tendon injury response is influenced by decorin and biglycan.	DCN BGN	1.01e-05	2	111	2	24072490
Pubmed	C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	21836066
Pubmed	Investigating the temporal roles of decorin and biglycan in tendon healing.	DCN BGN	1.01e-05	2	111	2	37132501
Pubmed	Extracellular matrix proteoglycans control the fate of bone marrow stromal cells.	DCN BGN	1.01e-05	2	111	2	15964849
Pubmed	Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration.	BGN POSTN	1.01e-05	2	111	2	12799472
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEF POTEE	1.01e-05	2	111	2	19669888
Pubmed	Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	24473438
Pubmed	Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	22972916
Pubmed	Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan.	DCN BGN	1.01e-05	2	111	2	19136671
Pubmed	Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	27188183
Pubmed	The injury response of aged tendons in the absence of biglycan and decorin.	DCN BGN	1.01e-05	2	111	2	24157578
Pubmed	Biglycan-like extracellular matrix genes of agnathans and teleosts.	DCN BGN	1.01e-05	2	111	2	11040287
Pubmed	Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	35575905
Pubmed	Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	30426302
Pubmed	CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	29749459
Pubmed	Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation.	DCN BGN	1.01e-05	2	111	2	25914258
Pubmed	CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	31837806
Pubmed	C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	28978553
Pubmed	Dermatan sulphate proteoglycans of human articular cartilage. The properties of dermatan sulphate proteoglycans I and II.	DCN BGN	1.01e-05	2	111	2	2590169
Pubmed	Ca2+/calmodulin kinase II-dependent regulation of βIV-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility.	SPTBN4 POSTN	1.01e-05	2	111	2	34153319
Pubmed	C1q/Tumor Necrosis Factor-Related Protein-9 Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	32283037
Pubmed	Serum Decorin and Biglycan as Potential Biomarkers to Predict PPROM in Early Gestation.	DCN BGN	1.01e-05	2	111	2	32436194
Pubmed	Transcriptomic profiling of fetal membranes of mice deficient in biglycan and decorin as a model of preterm birth†.	DCN BGN	1.01e-05	2	111	2	33165521
Pubmed	C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	27821723
Pubmed	A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.	DCN BGN	1.01e-05	2	111	2	21502335
Pubmed	C1q/tumour necrosis factor-related protein-9 aggravates lipopolysaccharide-induced inflammation via promoting NLRP3 inflammasome activation.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	35008006
Pubmed	Immunohistochemical identification of decorin and biglycan in human dentin: a correlative field emission scanning electron microscopy/transmission electron microscopy study.	DCN BGN	1.01e-05	2	111	2	17516017
Pubmed	C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	24030394
Pubmed	Biglycan and Decorin Expression and Distribution in Palatal Adhesion.	DCN BGN	1.01e-05	2	111	2	28759311
Pubmed	Regulation of pre-adipocyte proliferation and apoptosis by the small leucine-rich proteoglycans, biglycan and decorin.	DCN BGN	1.01e-05	2	111	2	21702857
Pubmed	C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	36766785
Pubmed	Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	37945738
Pubmed	Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species.	DCN BGN	1.01e-05	2	111	2	2647739
Pubmed	CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	22514273
Pubmed	WRN functions in a RAD18-dependent damage avoidance pathway.	RAD18 WRN	1.01e-05	2	111	2	17541157
Pubmed	Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion.	DCN POSTN	1.01e-05	2	111	2	25400079
Pubmed	Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases.	DCN BGN	1.01e-05	2	111	2	34638928
Pubmed	CTRP 9 mitigates the apoptosis and unfolded protein response of OGD/R-induced retinal ganglion cells by regulating the AMPK pathway.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	38741428
Pubmed	Decorin expression is important for age-related changes in tendon structure and mechanical properties.	DCN BGN	1.01e-05	2	111	2	23178232
Pubmed	Autoantibodies Against β1-Adrenoceptor Exaggerated Ventricular Remodeling by Inhibiting CTRP9 Expression.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	30764693
Pubmed	CTRP9 Regulates Growth, Differentiation, and Apoptosis in Human Keratinocytes through TGFβ1-p38-Dependent Pathway.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	29145717
Pubmed	Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.	EP300 MYB	1.01e-05	2	111	2	25740244
Pubmed	Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.	DCN BGN	1.01e-05	2	111	2	12102052
Pubmed	Uterine dysfunction in biglycan and decorin deficient mice leads to dystocia during parturition.	DCN BGN	1.01e-05	2	111	2	22253749
Pubmed	Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion.	CXCL2 CXCL3	1.01e-05	2	111	2	9277410
Pubmed	C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	26419929
Pubmed	MIB1-mediated degradation of WRN promotes cellular senescence in response to camptothecin treatment.	WRN MIB1	1.01e-05	2	111	2	32652764
Pubmed	Decorin and biglycan immunolocalization in non-villous structures of healthy and pathological human placentas.	DCN BGN	1.01e-05	2	111	2	24117774
Pubmed	Association of C1q/TNF-Related Protein-9 (CTRP9) Level with Obstructive Sleep Apnea in Patients with Coronary Artery Disease.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	32831639
Pubmed	Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively.	DCN BGN	1.01e-05	2	111	2	1968422
Pubmed	Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues.	DCN BGN	1.01e-05	2	111	2	2212616
Pubmed	More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders.	EP300 MYB	1.01e-05	2	111	2	16461764
Pubmed	Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth.	DCN BGN	1.01e-05	2	111	2	32804350
Pubmed	CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	38940054
Pubmed	Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	26754066
Pubmed	Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease.	DCN BGN	1.01e-05	2	111	2	16989735
Pubmed	c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.	EP300 MYB	1.01e-05	2	111	2	15691758
Pubmed	CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux.	C1QTNF9B C1QTNF9	1.01e-05	2	111	2	33352225
Pubmed	Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.	DCN BGN	1.01e-05	2	111	2	16938379
Pubmed	Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.	EP300 MYB	1.01e-05	2	111	2	24596419
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KNTC1 NRIP1 RAD18 LSM12 POTEE ZC3H7A SETDB1 SUPT6H POTEI MAPK9	1.98e-05	588	111	10	38580884
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK3 RSL1D1 PPFIBP1 SPTAN1 UBR4 UFL1 PSMD7 TRAPPC8 USP16 RSU1 SPICE1 ZC3H7A THADA SUPT6H MIB1 WDR41	2.03e-05	1487	111	16	33957083
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	SECISBP2L CUL4B ANK3 PPFIBP1 CNOT10 WRN PSMD7 COPS2 POSTN SETDB1 PTPDC1 THADA NF1 KATNIP FGD6	2.04e-05	1321	111	15	27173435
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	ANK3 NF1 EP300	2.49e-05	18	111	3	33323119
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	RAD18 SPTAN1 UBR4 RNF213 PSMD7 COPS2 USP16 SETDB1 UBASH3B	2.50e-05	481	111	9	28190767
Pubmed	Regional variation in human supraspinatus tendon proteoglycans: decorin, biglycan, and aggrecan.	DCN BGN	3.02e-05	3	111	2	22329809
Pubmed	Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.	CXCL2 CXCL3	3.02e-05	3	111	2	32416070
Pubmed	The interaction of polymorphisms in extracellular matrix genes and underlying miRNA motifs that modulate susceptibility to anterior cruciate ligament rupture.	DCN BGN	3.02e-05	3	111	2	28927971
Pubmed	Myeloperoxidase deficiency induces MIP-2 production via ERK activation in zymosan-stimulated mouse neutrophils.	CXCL2 CXCL3	3.02e-05	3	111	2	23438680
Pubmed	Regulation of macrophage inflammatory protein-2 gene expression in response to 2,4-dinitrofluorobenzene in RAW 264.7 cells.	CXCL2 CXCL3	3.02e-05	3	111	2	18452653
Pubmed	C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism.	C1QTNF9B C1QTNF9	3.02e-05	3	111	2	25870106
Pubmed	The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations.	CXCL2 CXCL3	3.02e-05	3	111	2	17670839
Pubmed	Genetic interaction between mutations in c-Myb and the KIX domains of CBP and p300 affects multiple blood cell lineages and influences both gene activation and repression.	EP300 MYB	3.02e-05	3	111	2	24340053
Pubmed	βIV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy.	ANK3 SPTBN4	3.02e-05	3	111	2	29861105
Pubmed	The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis.	EP300 MYB	3.02e-05	3	111	2	23618903
Pubmed	Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration.	CXCL2 CXCL3	3.02e-05	3	111	2	23904157
Pubmed	Cis-acting lnc-Cxcl2 restrains neutrophil-mediated lung inflammation by inhibiting epithelial cell CXCL2 expression in virus infection.	CXCL2 CXCL3	3.02e-05	3	111	2	34607953
Pubmed	Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.	CXCL2 CXCL3	3.02e-05	3	111	2	20840653
Pubmed	Early infiltrating NKT lymphocytes attenuate bone regeneration through secretion of CXCL2.	CXCL2 CXCL3	3.02e-05	3	111	2	38758783
Pubmed	βIV-Spectrin/STAT3 complex regulates fibroblast phenotype, fibrosis, and cardiac function.	SPTBN4 POSTN	3.02e-05	3	111	2	31550236
Pubmed	Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves.	DCN BGN	3.02e-05	3	111	2	18621549
Pubmed	Pyrrolidine dithiocarbamate-induced macrophage inflammatory protein-2 gene expression is NF-kappaB-independent but c-Jun-dependent in macrophage cell line RAW 264.7.	CXCL2 CXCL3	3.02e-05	3	111	2	15829306
Pubmed	Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells.	POU5F1B SETDB1	3.02e-05	3	111	2	19884257
Interaction	POTEC interactions	POTEB3 POTEF POTEG POTED POTEC	5.25e-09	13	109	5	int:POTEC
Interaction	C3orf18 interactions	KNTC1 VPS8 UFL1 THADA NF1 COMMD2 INTS4 MAPK9	2.07e-07	115	109	8	int:C3orf18
Interaction	POTED interactions	POTEB3 POTED POTEC	6.13e-07	4	109	3	int:POTED
Interaction	CUL4A interactions	CUL4B KNTC1 ANK3 UBR4 RNF213 ARMC10 VTA1 TRAPPC8 IFI16 COPS2 RSU1 LSM12 GLMN MIB1 EP300 MYB	1.40e-05	854	109	16	int:CUL4A
Interaction	BTNL9 interactions	KNTC1 PPFIBP1 VPS8 TAOK2 SETDB1 THADA INTS4	2.24e-05	156	109	7	int:BTNL9
Interaction	SUPT16H interactions	CUL4B RAD18 RSL1D1 WRN UFL1 IFI16 SPICE1 LRRC31 SUPT6H COMMD2 EP300	2.78e-05	442	109	11	int:SUPT16H
Interaction	POTEG interactions	POTEF POTEG POTEC	3.27e-05	12	109	3	int:POTEG
Interaction	SIGLECL1 interactions	KNTC1 VPS8 RNF213 THADA NF1 INTS4	3.44e-05	113	109	6	int:SIGLECL1
Interaction	POTEB3 interactions	POTEB3 POTEF POTED POTEC	3.73e-05	35	109	4	int:POTEB3
Interaction	MAPK8IP3 interactions	NRIP1 ANK3 TAOK2 MAPK9 EP300	3.86e-05	70	109	5	int:MAPK8IP3
Interaction	GYPA interactions	KNTC1 VPS8 UFL1 URB2 GLMN THADA NF1	4.51e-05	174	109	7	int:GYPA
Interaction	CD80 interactions	KNTC1 POTEF UFL1 THADA NF1	6.92e-05	79	109	5	int:CD80
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEF POTEG POTED POTEC POTEE POTEM POTEI	3.55e-14	13	78	7	685
GeneFamily	Ankyrin repeat domain containing	ASZ1 ANK3 POTEF POTEG POTED POTEC POTEE POTEM MIB1 PPP1R16B POTEI	6.95e-09	242	78	11	403
GeneFamily	EF-hand domain containing\|Spectrins	SPTAN1 SPTBN4	3.80e-04	7	78	2	1113
GeneFamily	Small leucine rich repeat proteoglycans	DCN BGN	1.18e-03	12	78	2	573
GeneFamily	Exonucleases	AEN WRN	2.12e-03	16	78	2	544
GeneFamily	Dyneins, axonemal	DNAH8 DNAH9	2.40e-03	17	78	2	536
GeneFamily	Endogenous ligands\|C1q and TNF related	C1QTNF9B C1QTNF9	2.69e-03	18	78	2	1372
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	MIB1 EP300	2.69e-03	18	78	2	91
GeneFamily	NLR family	NLRC4 NLRP8	5.17e-03	25	78	2	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	IFI16 NLRP8	5.17e-03	25	78	2	994
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_B	POTEB3 FBXW10 CNOT10 POTEF POTEG GDAP1 PSMD7 POU5F1B POTEC POTEE POTEM POTEI	7.11e-06	584	111	12	MM1080
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	CUL4B KNTC1 RAD18 ASZ1 RNF213 URB2 TRAPPC8 SPICE1 DMC1 THADA SMS DGCR8 DNAH8 FGD6 MYB	1.98e-05	822	109	15	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	STEAP4 DCN BGN POSTN SERPING1	7.69e-05	85	109	5	GSM777067_100
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	CUL4B KNTC1 RAD18 ASZ1 ICE2 URB2 TRAPPC8 SPICE1 DMC1 SETDB1 SMS DGCR8 DNAH8 FGD6	7.84e-05	820	109	14	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	STEAP4 DCN BGN POSTN SERPING1	8.13e-05	86	109	5	GSM777055_100
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	STEAP4 DCN BGN POSTN SERPING1	8.59e-05	87	109	5	GSM777050_100
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#3_top-relative-expression-ranked_200	BGN POSTN SERPING1	1.20e-04	19	109	3	gudmap_kidney_adult_Mesangium_Meis_k3_200
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	STEAP4 DCN BGN POSTN SERPING1	1.44e-04	97	109	5	GSM777043_100
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	PPFIBP1 DCN IFI16 CXCL2 BGN POSTN SERPING1	7.54e-07	200	112	7	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	PPFIBP1 DCN IFI16 CXCL2 BGN POSTN SERPING1	7.54e-07	200	112	7	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	RNF213 ZNFX1 IFI16 CXCL2 CXCL3 FGD6	6.98e-06	183	112	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	5'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STEAP4 DCN CXCL2 BGN SERPING1 PAPPA	8.91e-06	191	112	6	054e9a79bd1486fd812bc7418fb091664fe3a646
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STEAP4 DCN CXCL2 BGN SERPING1 PAPPA	9.18e-06	192	112	6	9479e9859140ba98abfe88414de0b28fc2bf43b7
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STEAP4 DCN CXCL2 BGN SERPING1 PAPPA	9.18e-06	192	112	6	d7faa993f68e530ad55185505384ae155d36c222
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 PPP1R16B MYRF	9.18e-06	192	112	6	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 PPP1R16B MYRF	9.74e-06	194	112	6	cb0422e7607dbd77204428b7e2c70dfe14a6ca11
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.03e-05	196	112	6	37a5f9f3988778655580bd0383811bb4930c1551
ToppCell	368C\|World / Donor, Lineage, Cell class and subclass (all cells)	DCN CXCL2 CXCL3 BGN SERPING1 PAPPA	1.06e-05	197	112	6	f41211923938e5d7bfe6bf24f604ab386f17ef10
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DCN CXCL2 CXCL3 BGN POSTN SERPING1	1.16e-05	200	112	6	2518d1758e2730b028270e76b949cebbeb7fb5ce
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.16e-05	200	112	6	829978708463a7459fe1041bd90196775bc4b531
ToppCell	TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11\|TCGA-Brain / Sample_Type by Project: Shred V9	POTEF POTEG POTEE POTEI	1.94e-05	63	112	4	d7dc1356a60cb527fe668328d5375f352239d911
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	STEAP4 CXCL2 CXCL3 SERPING1 VWA3B	3.09e-05	143	112	5	4c5a5db46beb8f2f3c40e8ed95911fbfea61bae0
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RSPH14 VWA3B DNAH9 ODAD3 MYB	4.40e-05	154	112	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RSPH14 VWA3B DNAH9 ODAD3 MYB	4.40e-05	154	112	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN CXCL3 PCDHB16 C1QTNF9 SERPING1	5.27e-05	160	112	5	8590281165eab6514a9f6a022b900d4c222c1044
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RSPH14 EYS VWA3B DNAH9 NLRP8	5.93e-05	164	112	5	9e16e52f5a634585f26021bcce9b5d5992ff6db0
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBXW10 NT5E TRAPPC8 PCDHB16 PLCH2	6.28e-05	166	112	5	3b67064a5149e72f895344d938c64b8ff65247f5
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STEAP4 DCN BGN GLMN SERPING1	6.65e-05	168	112	5	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SECISBP2L SPICE1 KIAA1328 MAPK9 FGD6	6.83e-05	169	112	5	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9\|TCGA-Breast / Sample_Type by Project: Shred V9	POTEF POTEE POTEM POTEI	7.88e-05	90	112	4	96e836c7a1df279ac812b7c3aa75e6b81b614244
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-SMG_basal_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	RSPH14 CXCL2 CXCL3 MYO3A MYB	8.06e-05	175	112	5	4462000b22af227555413ba202a872868eecde6c
ToppCell	metastatic_Brain-Fibroblasts-Undetermined\|metastatic_Brain / Location, Cell class and cell subclass	PPFIBP1 DCN BGN POSTN DNAH9	8.50e-05	177	112	5	54f39be5d90363cfd44dea1a96ae06d3143aa795
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN CXCL3 PCDHB16 C1QTNF9 SERPING1	8.73e-05	178	112	5	6d9ecfaeb50d562899380de379ebf7b99fd8adc9
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN CXCL3 PCDHB16 C1QTNF9 SERPING1	8.73e-05	178	112	5	d3f518cd75b02e85d45cbb9b2eff30f0272512a8
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RSPH14 VWA3B DNAH9 ODAD3 MYB	8.73e-05	178	112	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ANK3 RNF213 ZNFX1 IFI16 DNAH9	8.96e-05	179	112	5	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEF POTEG RSU1 POTEE POTEI	9.20e-05	180	112	5	fb3d549c2a69b2157a486786ddd775ca16699ed0
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEF POTEG RSU1 POTEE POTEI	9.20e-05	180	112	5	beb4d777e0c5fa0a59672dbc3dbb7732498605ff
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STEAP4 DCN CXCL2 SERPING1 PAPPA	9.44e-05	181	112	5	ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	RSPH14 VWA3B DNAH9 ODAD3 MYB	9.69e-05	182	112	5	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	EMILIN3 DCN POSTN SERPING1 MYRF	9.69e-05	182	112	5	354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCell	droplet-Mammary_Gland-nan-18m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN POSTN SERPING1	1.02e-04	184	112	5	fe4d3def3da4ffdea5ae6bb059f5397efd58fef3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 DCN POSTN PAPPA UBASH3B	1.05e-04	185	112	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	RSPH14 VWA3B DNAH9 ODAD3 MYB	1.05e-04	185	112	5	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AEN URB2 FRAT2 MIB1 KIAA1328	1.07e-04	186	112	5	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN POSTN SERPING1	1.07e-04	186	112	5	cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	AEN URB2 FRAT2 MIB1 KIAA1328	1.07e-04	186	112	5	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	15-Trachea-Epithelial-Secretory_progenitor\|Trachea / Age, Tissue, Lineage and Cell class	NT5E STEAP4 PLXND1 CXCL2 SERPING1	1.10e-04	187	112	5	be9fce9e74b2f170a2067f1b31d802912a578329
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NT5E DCN BGN POSTN SERPING1	1.16e-04	189	112	5	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCN POSTN EYS PAPPA UBASH3B	1.19e-04	190	112	5	d19bc44310c53726e2f5f6a2bd377bbbf1d1983f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 SPTAN1 ZC3H7A THADA KIAA1328	1.19e-04	190	112	5	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN SERPING1 PAPPA	1.22e-04	191	112	5	6cab0334f76c973880bd8d1638856f2f6e4a249a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN SERPING1 PAPPA	1.22e-04	191	112	5	850c6fff6dc795431ef534fdaa41e4ad50f7367a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN SERPING1 PAPPA	1.22e-04	191	112	5	8b2b00202d3c98bccbae1b4a23713892fad0ff23
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DCN BGN POSTN SERPING1 PAPPA	1.22e-04	191	112	5	9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 PPP1R16B MYRF	1.25e-04	192	112	5	8dc3016601148243196e925641c9507e9d58c9e0
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMILIN3 PLXND1 DCN BGN SPTBN4	1.28e-04	193	112	5	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCN POSTN EYS PAPPA UBASH3B	1.28e-04	193	112	5	53bcd50892c379b2a571751f6eb1062436339fe7
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCN POSTN EYS PAPPA UBASH3B	1.28e-04	193	112	5	5581a5ebcd21a2a8062ccfb917f088ec67a10a9c
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	NRIP1 RSL1D1 RNF213 SERPING1 UBASH3B	1.31e-04	194	112	5	6cf9d59aec8dd18fa2fc1652ddd0f5ef1f24bcb6
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN PCDHB16 BGN POSTN SERPING1	1.31e-04	194	112	5	bbc625b4cc53bb7d6254fde287258e51f9171572
ToppCell	facs-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN PCDHB16 BGN POSTN SERPING1	1.31e-04	194	112	5	fcd5e9238d299c41f0bf9693b56cd8c900d2112b
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STEAP4 DCN BGN POSTN SERPING1	1.31e-04	194	112	5	2d0cff9dc538a14518741e2a96d9d78442c81a72
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	STEAP4 DCN CXCL2 PAPPA UBASH3B	1.31e-04	194	112	5	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	facs-Kidney-nan-18m-Mesenchymal-mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCN PCDHB16 BGN POSTN SERPING1	1.31e-04	194	112	5	6afc21c5fec30ab8e373e3e46ab7866204c805b6
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASZ1 DCN BGN POSTN SERPING1	1.34e-04	195	112	5	d663d54a4bcc94e2c9b50ed931e2b2db4ca41373
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 UFL1 DCN SERPING1 UBASH3B	1.34e-04	195	112	5	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRIM2 ANK3 NT5E STEAP4 PROM2	1.34e-04	195	112	5	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	PLCH2 VWA3B DNAH9 ODAD3 MYB	1.34e-04	195	112	5	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	DCN IFI16 NLRC4 SERPING1 PAPPA	1.34e-04	195	112	5	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	STEAP4 RNF213 IFI16 FRAT2 SERPING1	1.37e-04	196	112	5	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	PPFIBP1 DCN BGN POSTN PAPPA	1.40e-04	197	112	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 ANK3 PLCH2 MYRF	1.40e-04	197	112	5	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	(1)_T_cell-(15)_Treg\|(1)_T_cell / shred on Cell_type and subtype	ZC3H7A THADA SMS DNAH8 MYB	1.40e-04	197	112	5	6e7723e8b977be35c60cc11ac7cfa4f71339441e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.44e-04	198	112	5	bdabdb11217ea16e5863aa6bfb0f04d48b17f81e
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	PPFIBP1 DCN BGN POSTN SERPING1	1.44e-04	198	112	5	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	Non-neuronal-Postmitotic-Mural-Mural\|World / Primary Cells by Cluster	PLXND1 DCN CXCL2 CXCL3 BGN	1.44e-04	198	112	5	9fc1035ea447a4551a66944c869c4671e17cec61
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 STEAP4 DCN BGN SERPING1	1.44e-04	198	112	5	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	Non-neuronal-Postmitotic-Mural\|World / Primary Cells by Cluster	PLXND1 DCN CXCL2 CXCL3 BGN	1.44e-04	198	112	5	dd38840a96171f58da243daa22b013e15a81db4a
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PPFIBP1 STEAP4 DCN BGN SERPING1	1.44e-04	198	112	5	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	Non-neuronal-Postmitotic-Mural-Mural-18\|World / Primary Cells by Cluster	PLXND1 DCN CXCL2 CXCL3 BGN	1.44e-04	198	112	5	21efb7bcd24f24d20791b34e75d6f9d46a129481
ToppCell	MS-IIF-Others-HSPC\|IIF / Disease, condition lineage and cell class	NRIP1 CXCL3 SERPING1 TLCD3A MYB	1.47e-04	199	112	5	3384db80f6024bcabe2625f24d5f4e0d3d8caa7e
ToppCell	metastatic_Brain-Fibroblasts-FB-like_cells\|metastatic_Brain / Location, Cell class and cell subclass	DCN BGN POSTN SERPING1 PAPPA	1.47e-04	199	112	5	12133087eae9f0e9b6c13a71e8187117768e64ce
ToppCell	(5)_Epi_suprabasal\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	RSL1D1 DCN IFI16 CXCL2 BGN	1.47e-04	199	112	5	e1d0fd71b2f3925d02638413f2155db009f103d9
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCN BGN POSTN SERPING1 PAPPA	1.47e-04	199	112	5	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	metastatic_Brain-Fibroblasts\|metastatic_Brain / Location, Cell class and cell subclass	DCN BGN POSTN SERPING1 PAPPA	1.47e-04	199	112	5	63eb2106bb6e2e33d020628583536c8d96662c84
ToppCell	Macroglial-Oligodendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.51e-04	200	112	5	4dbac2f2587e87ca5a0622f50439bb5447e93c7f
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PPFIBP1 DCN BGN POSTN SERPING1	1.51e-04	200	112	5	e663995fc44c340d878d66b278b7b5c2ff784301
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTAN1 RNF213 IFI16 TAOK2 FGD6	1.51e-04	200	112	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPFIBP1 RNF213 IFI16 NF1 SERPING1	1.51e-04	200	112	5	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SPTAN1 TAOK2 WDR41 MAPK9 FGD6	1.51e-04	200	112	5	1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	acdef0b9096c774040948fc75621ff2b08ea2ee8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RSPH14 VWA3B DNAH9 ODAD3 MYB	1.51e-04	200	112	5	926a7ea94b5908aebf103893ea83ce9d25285b65
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RSPH14 VWA3B DNAH9 ODAD3 MYB	1.51e-04	200	112	5	af6a551f83808c1c839df7ba7b1702ca28ea6e1b
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DCN BGN POSTN SERPING1 PAPPA	1.51e-04	200	112	5	8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	091a18d6efed81cab99955c3047f172170f70476
ToppCell	Macroglial-Oligodendrocytes-OPALIN--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.51e-04	200	112	5	26b989e30bbbaf30904ced03f6aae3dea25c732c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	3b8513defe25262ab4b492345b2628570eaefd17
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RSPH14 VWA3B DNAH9 ODAD3 MYB	1.51e-04	200	112	5	73ac1cf40ddd764be1100cbfaaa29563665457d8
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPFIBP1 DCN BGN POSTN SERPING1	1.51e-04	200	112	5	2cb8a39a12522a9643c6244d5e94cb4559868bb9
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	159377d904394d91e09913131e9a93e08189955a
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PPFIBP1 DCN BGN POSTN SERPING1	1.51e-04	200	112	5	8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SECISBP2L ABCA2 TRIM2 ANK3 MYRF	1.51e-04	200	112	5	d30316836494f33ca46d4e415fd2ed179e9cb5ee
ToppCell	Macroglial-Oligodendrocytes-OPALIN---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.51e-04	200	112	5	1314664c1721e9ecb1e2c3482a039044b0fe50a9
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RSPH14 VWA3B DNAH9 ODAD3 MYB	1.51e-04	200	112	5	06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb
ToppCell	Macroglial-Oligodendrocytes-OPALIN-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ABCA2 TRIM2 ANK3 PPP1R16B MYRF	1.51e-04	200	112	5	8b229f095fc113aecfc94b64862a9e0fdcc363ce
ToppCell	(5)_Epithelial_cells-(5)_Epi_suprabasal\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	RSL1D1 DCN IFI16 CXCL2 BGN	1.51e-04	200	112	5	92382ca82da3e435ccbee1c73261d55164d54779
Disease	skin disease (implicated_via_orthology)	C1QTNF9B C1QTNF9	3.54e-05	3	102	2	DOID:37 (implicated_via_orthology)
Disease	viral pneumonia (biomarker_via_orthology)	CXCL2 CXCL3	3.54e-05	3	102	2	DOID:10533 (biomarker_via_orthology)
Disease	degenerative disc disease (is_marker_for)	POSTN PAPPA	7.07e-05	4	102	2	DOID:90 (is_marker_for)
Disease	acute necrotizing pancreatitis (biomarker_via_orthology)	CXCL2 CXCL3 SERPING1	9.84e-05	26	102	3	DOID:0080998 (biomarker_via_orthology)
Disease	aspiration pneumonia (biomarker_via_orthology)	CXCL2 CXCL3	1.76e-04	6	102	2	DOID:0050152 (biomarker_via_orthology)
Disease	esophageal cancer (biomarker_via_orthology)	CXCL2 CXCL3	1.76e-04	6	102	2	DOID:5041 (biomarker_via_orthology)
Disease	severe acute respiratory syndrome (biomarker_via_orthology)	CXCL2 CXCL3	3.27e-04	8	102	2	DOID:2945 (biomarker_via_orthology)
Disease	vitamin D-dependent rickets (implicated_via_orthology)	CXCL2 CXCL3	3.27e-04	8	102	2	DOID:0080883 (implicated_via_orthology)
Disease	neutrophil measurement	SMAP1 FRAT2 GLMN THADA MYB	3.82e-04	177	102	5	EFO_0803548
Disease	status epilepticus (biomarker_via_orthology)	ANK3 NT5E CXCL2 CXCL3	4.09e-04	100	102	4	DOID:1824 (biomarker_via_orthology)
Disease	pneumonia (biomarker_via_orthology)	CXCL2 CXCL3	6.38e-04	11	102	2	DOID:552 (biomarker_via_orthology)
Disease	Paranoia	ICE2 DNAH8	6.38e-04	11	102	2	C1456784
Disease	bronchopulmonary dysplasia (biomarker_via_orthology)	CXCL2 CXCL3	7.64e-04	12	102	2	DOID:11650 (biomarker_via_orthology)
Disease	prostatitis (biomarker_via_orthology)	CXCL2 CXCL3	7.64e-04	12	102	2	DOID:14654 (biomarker_via_orthology)
Disease	severe acute respiratory syndrome, COVID-19	POTEF GDAP1 WRN VTA1 EYS WDR41 MYB	9.37e-04	447	102	7	EFO_0000694, MONDO_0100096
Disease	bacterial pneumonia (biomarker_via_orthology)	CXCL2 CXCL3	1.05e-03	14	102	2	DOID:874 (biomarker_via_orthology)
Disease	Endometrial Neoplasms	NRIP1 DCN EP300	1.08e-03	58	102	3	C0014170
Disease	Malignant neoplasm of breast	NRIP1 SPTAN1 UBR4 TRAPPC8 CXCL2 CXCL3 BGN NF1 DNAH9 EP300 NLRP8	1.23e-03	1074	102	11	C0006142
Disease	Moyamoya Disease	RNF213 NF1	1.56e-03	17	102	2	C0026654
Disease	phosphatidylcholine 40:6 measurement	MYRF DNAH9	1.56e-03	17	102	2	EFO_0010389
Disease	esophageal adenocarcinoma	ASZ1 PTPDC1	1.75e-03	18	102	2	EFO_0000478
Disease	Endometrial Carcinoma	NRIP1 DCN EP300	2.01e-03	72	102	3	C0476089
Disease	migraine disorder, endometriosis	EYS MAPK9 FGD6	2.09e-03	73	102	3	EFO_0001065, MONDO_0005277
Disease	periodontitis (biomarker_via_orthology)	CXCL2 POSTN	2.38e-03	21	102	2	DOID:824 (biomarker_via_orthology)
Disease	dilated cardiomyopathy (biomarker_via_orthology)	CXCL2 CXCL3	2.61e-03	22	102	2	DOID:12930 (biomarker_via_orthology)
Disease	Anhedonia	ANK3 SETDB1	3.11e-03	24	102	2	C0178417
Disease	migraine disorder, Headache	RNF213 UFL1 PAPPA	3.33e-03	86	102	3	HP_0002315, MONDO_0005277
Disease	systemic mastocytosis	ABCA2 EYS	3.37e-03	25	102	2	MONDO_0016586
Disease	diet measurement	SECISBP2L RSPH14 ANK3 EMILIN3 COPS2 PCDHB16 THADA NF1 KIAA1328 CAPZA3	3.43e-03	1049	102	10	EFO_0008111

Protein segments in the cluster

Peptide	Gene	Start	Entry
NILHSRKLQNLLKNG	URB2	76	Q14146
LLKNGKTINLQISLV	URB2	86	Q14146
LLQNQLKDIQSHGII	CAPZA3	96	Q96KX2
DLALQLLHKKIQVGQ	AEN	236	Q8WTP8
KLIQQQLVLLLHAHK	EP300	336	Q09472
GKLQKILRQLHQSCQ	COPS2	166	P61201
LEIQKLQPNLKISLH	FBXW10	886	Q5XX13
LLQKHGINVADIKKL	DMC1	26	Q14565
VGKQLASQKILQLLH	DGCR8	671	Q8WYQ5
LQTLQGIHLKNIQSV	CXCL3	46	P19876
NGNTKVQVLKLLLNL	ARMC10	231	Q8N2F6
LKLNKQCGHLITAVQ	ASZ1	361	Q8WWH4
KEHGLSIQGNKQQLI	RAD18	261	Q9NS91
GIHLALVELLKNLTK	INTS4	481	Q96HW7
TLQISHIAQQLGLEK	POU5F1B	256	Q06416
LLKCVNHKNIISLLN	MAPK9	76	P45984
LLLGVHEQKQQVVKF	POTEF	276	A5A3E0
LEGQQLFQTIHKTIK	LSM12	111	Q3MHD2
AIGLHNQTLKIAVNL	EYS	3031	Q5T1H1
AVKILAQNLHNLVKL	NLRC4	836	Q9NPP4
NLQGNGHLKTLILRK	NLRP8	811	Q86W28
LHRKKLQLALQALGS	PPFIBP1	696	Q86W92
LGSRQQQKLLKVLQA	KATNIP	426	O60303
LLLCAIKQQINKGSI	PLXND1	1516	Q9Y4D7
KGLQHLYALVLVNNK	BGN	111	P21810
NLHALILVNNKISKV	DCN	106	P07585
RQQIKPAVTIKLHLN	COMMD2	141	Q86X83
GSNKSLALHLIQNIL	CES5A	361	Q6NT32
VINVLNVAHSKLLKN	DNAH8	201	Q96JB1
KVLGHVNNILISAVL	GDAP1	291	Q8TB36
IQTGHLAKLQKLDLS	LRRC31	446	Q6UY01
IKQAANNSLLLHLLK	NRIP1	371	P48552
KLNSHQKVTLLQLLL	NRIP1	491	P48552
QKVTLLQLLLGHKNE	NRIP1	496	P48552
NININQALSILKHLK	KNTC1	1546	P50748
IVHQGTILDNVKNLL	MYB	376	P10242
AQILVGHKPRQQKLI	PTPDC1	416	A2A3K4
LKNILKLDGSTHLNI	PAPPA	501	Q13219
SSKGHLLKQVLQIQK	GTPBP8	231	Q8N3Z3
HLLAQQETKLLLKQQ	KIAA1328	386	Q86T90
ASQNGHVDILKLLLK	MIB1	471	Q86YT6
IAVNKGHLQVVKTLL	MIB1	536	Q86YT6
LLLGVHEQKQQVVKF	POTEB3	276	A0JP26
LLLGVHEQKQQVVKF	POTEE	276	Q6S8J3
IVKLLLSHGANVNAK	PPP1R16B	116	Q96T49
NKQHLQLKAQTGDLL	PCDHB16	71	Q9NRJ7
NVQVSLVKNGVKILH	C1QTNF9	261	P0C862
LKISNLFNILQHILK	ICE2	836	Q659A1
LQTLQGIHLKNIQSV	CXCL2	46	P19875
NVQVSLVKNGVKILH	C1QTNF9B	261	B2RNN3
HSVLKELLQVQQSLG	ABCA2	2116	Q9BZC7
GNIKIVNFLLQHSAK	ANK3	741	Q12955
KAKVGQLQLSHNLSL	SERPING1	341	P05155
TLKIDILHKQASGNI	IFI16	301	Q16666
TLQTKVQLLDKVHGL	EMILIN3	261	Q9NT22
NLIKESGLKIHALVQ	DNAH9	851	Q9NYC9
LQKQIRQLESHLSLG	PEX11B	41	O96011
KQLLGEHLTAILQKG	CUL4B	446	Q13620
HRLLQQLVLSGNLIK	FRAT2	176	O75474
QNKLILKGELITLLH	PTCD2	86	Q8WV60
NIKIHETQPLLNLKL	PCGF1	86	Q9BSM1
LLSGQLNTLNKVLKH	MED8	51	Q96G25
LLLGVHEQKQQVVKF	POTEC	276	B2RU33
LLLGVHEQKQQVVKF	POTED	276	Q86YR6
LQPLQTVIQKLHNKA	GLMN	126	Q92990
QLKELHIQGNRLTVL	RSU1	181	Q15404
KILHSKQFGNILILS	SMS	151	P52788
NNLLKNVLHFLQKSL	THADA	156	Q6YHU6
QSLQLVHQLKGLIVL	PRLHR	51	P49683
ITNQVHGLKGLNSKL	PSMD7	191	P51665
KLLKLQAQLQGHDVQ	ODAD3	506	A5D8V7
QHILGQQKKELAALL	TAOK2	566	Q9UL54
GSVVPKQQLLQQHIK	SECISBP2L	171	Q93073
LLLGVHEQKQQVVKF	POTEI	276	P0CG38
GHIETVIKKLQNQVL	VPS8	986	Q8N3P4
SLNSLVKHLLGKQLL	WRN	176	Q14191
VGHVLNSRKQKQLLN	SPICE1	281	Q8N0Z3
LVQHGLQVRLQLFKT	SETDB1	796	Q15047
KLKTLNVNKIIALGH	NT5E	206	P21589
QIIKRNQLLPAVKTH	CNOT10	701	Q9H9A5
KGTHLLKILKQNNTR	SUPT6H	996	Q7KZ85
ILVGQLELIIKHKNQ	RNF213	1101	Q63HN8
RQQKIQGKVLHLNDI	USP16	456	Q9Y5T5
LSQLLGLRKNISIHQ	PROM2	531	Q8N271
KLLNKHGIKTVSQII	RSL1D1	116	O76021
ALGSNVVLVLKQKLL	RSPH14	186	Q9UHP6
AVQNLQKALKLLTTG	VTA1	291	Q9NP79
IGEVLQLLHKLNVNL	PLCH2	191	O75038
LIGVQNLLKKHQALQ	SPTAN1	816	Q13813
SLGRVLIQLKQQHTL	TLCD3A	161	Q8TBR7
LKINKISVLHQNVLC	FGD6	356	Q6ZV73
KSLKNQHGLTLQLHL	ZNF534	116	Q76KX8
HGQIKQIIRILSKAL	NF1	2261	P21359
LGKNLHQQATLQLRK	TMDD1	146	P0DPE3
QKLNEQHQLILSKLL	SMAP1	11	Q8IYB5
TLQLLKKHLQLEQGV	SPTBN4	1656	Q9H254
LNGKILVDISNNLKI	STEAP4	96	Q687X5
RQSVLHVLGILKNSK	ZNFX1	201	Q9P2E3
KQLGLSVDVLQHLKQ	YAE1	211	Q9NRH1
GKINLTVFKLLQEHL	ZC3H7A	551	Q8IWR0
LHGKILKSNLSLVNQ	ZNF613	131	Q6PF04
QLHVIKNLKIAVSNI	TRAPPC8	61	Q9Y2L5
NQGKHLLQVLFTNKL	ZNF782	96	Q6ZMW2
ILKGLQQENHLKIRV	UBASH3B	481	Q8TF42
QLHGLKSNKLTLKQI	VWA3B	41	Q502W6
GLKHKVLQSQLDTLL	TRIM2	231	Q9C040
KLILQNHILKVKVGL	POSTN	426	Q15063
HQLKDLILQKGITQN	UBR4	4676	Q5T4S7
LLLGVHEQKQQVVKF	POTEG	276	Q6S5H5
LLLGVHEQKQQVVKF	POTEM	276	A6NI47
LQLHGKGQLQTLSQK	TMEM234	136	Q8WY98
KLLELNGHTQKITAI	WDR41	76	Q9HAD4
TSQKVDLALKQLGHI	TRPM4	1151	Q8TD43
IKSEKHVQLVLGQLI	UFL1	101	O94874
AHLLVQQLTVLGKAN	MYO3A	441	Q8NEV4
LKLHGVKLEALNQSI	MYRF	431	Q9Y2G1